Atreca, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- 90
- Market Cap
- -
- Website
- http://www.atreca.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies
Phase 1
Terminated
- Conditions
- Breast CancerColorectal CancerOvarian CancerNon-Small Cell Lung CancerAcral Lentiginous MelanomaHead and Neck Squamous Cell CarcinomaHepatocellular CarcinomaEsophageal Squamous Cell CarcinomaUrothelial CarcinomaDMMR Colorectal Cancer
- Interventions
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2023-12-29
- Lead Sponsor
- Atreca, Inc.
- Target Recruit Count
- 87
- Registration Number
- NCT04244552
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸The University of Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸City of Hope, Duarte, California, United States
News
No news found